Develco Pharma Schweiz AG
About Develco Pharma Schweiz AG
-
CH -
2024On CPHI since
Products from Develco Pharma Schweiz AG (1)
-
Product Develco Pharma Schweiz AG Product List
API Formulation Strength Reference Product Regulatory Status Hydromorphone Immediate release capsule 1.3 - 2.6 mg Palladone® capsule Approved in the EU Prolonged release tablet - twice daily dosing 4 - 8 - 16 - 24 mg Palladone® prolonged release capsule Approved in the EU Prolonged release tablet - once...
Develco Pharma Schweiz AG Resources (1)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance